These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 19577543)
1. CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha. Guo X; Li T; Wang Y; Shao L; Zhang Y; Ma D; Han W Biochem Biophys Res Commun; 2009 Sep; 387(1):139-42. PubMed ID: 19577543 [TBL] [Abstract][Full Text] [Related]
2. CMTM5-v1 induces apoptosis in cervical carcinoma cells. Shao L; Guo X; Plate M; Li T; Wang Y; Ma D; Han W Biochem Biophys Res Commun; 2009 Feb; 379(4):866-71. PubMed ID: 19124004 [TBL] [Abstract][Full Text] [Related]
3. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Shao L; Cui Y; Li H; Liu Y; Zhao H; Wang Y; Zhang Y; Ng KM; Han W; Ma D; Tao Q Clin Cancer Res; 2007 Oct; 13(19):5756-62. PubMed ID: 17908965 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia. Niu J; Li H; Zhang Y; Li J; Xie M; Li L; Qin X; Qin Y; Guo X; Jiang Q; Liu Y; Chen S; Huang X; Han W; Ruan G Leuk Res; 2011 Jun; 35(6):771-6. PubMed ID: 21168207 [TBL] [Abstract][Full Text] [Related]
5. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma. Zhang H; Nan X; Li X; Chen Y; Zhang J; Sun L; Han W; Li T Biochem Biophys Res Commun; 2014 May; 447(2):304-10. PubMed ID: 24721428 [TBL] [Abstract][Full Text] [Related]
6. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237 [TBL] [Abstract][Full Text] [Related]
7. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5]. Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412 [TBL] [Abstract][Full Text] [Related]
8. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death. Basu A; Haldar S Int J Oncol; 2009 Jan; 34(1):281-6. PubMed ID: 19082499 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Zhang D; Ma Q; Shen S; Hu H Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745 [TBL] [Abstract][Full Text] [Related]
10. The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines. Lyu MA; Kurzrock R; Rosenblum MG Biochem Pharmacol; 2008 Feb; 75(4):836-46. PubMed ID: 18082672 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of CMTM5 on xenografted human prostatic cancer in nude mice]. Xiao YB; Xie J; Zhang GX; Li J; Hao YC; Zhang XW; Liu ZH; Xu T; Wang XF Zhonghua Nan Ke Xue; 2012 Mar; 18(3):195-9. PubMed ID: 22474980 [TBL] [Abstract][Full Text] [Related]
12. [Abnormally lower expression of cmtm5 gene in bone marrow cells from patients with multiple myeloma]. Niu JH; Bao L; Zhang Y; Li JL; Li LD; Xie M; Qin YZ; Lai YY; Jiang Q; Shi HL; Liu YR; Jiang B; Chen SS; Huang XJ; Ruan GR Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):363-7. PubMed ID: 20416169 [TBL] [Abstract][Full Text] [Related]
13. Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer. Li P; Liu K; Li L; Yang M; Gao W; Feng J; Lv Y; Qu X; Kong B Int J Gynecol Cancer; 2011 Oct; 21(7):1248-55. PubMed ID: 21841490 [TBL] [Abstract][Full Text] [Related]
14. Claudin-1 expression is induced by tumor necrosis factor-alpha in human pancreatic cancer cells. Kondo J; Sato F; Kusumi T; Liu Y; Motonari O; Sato T; Kijima H Int J Mol Med; 2008 Nov; 22(5):645-9. PubMed ID: 18949385 [TBL] [Abstract][Full Text] [Related]
15. CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo. Xiao Y; Yuan Y; Zhang Y; Li J; Liu Z; Zhang X; Sheng Z; Xu T; Wang X Clin Transl Oncol; 2015 Jun; 17(6):431-7. PubMed ID: 25387568 [TBL] [Abstract][Full Text] [Related]
16. CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway. Li H; Guo X; Shao L; Plate M; Mo X; Wang Y; Han W BMB Rep; 2010 Mar; 43(3):182-7. PubMed ID: 20356458 [TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of CMTM5 and epidermal growth factor receptor in prostate cancer]. Yuan YQ; Zhang YX; Liu ZH; Qin CP; Sheng ZZ; Xu T; Wang XF Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):571-6. PubMed ID: 26284387 [TBL] [Abstract][Full Text] [Related]
18. Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells. Badiola N; Malagelada C; Llecha N; Hidalgo J; Comella JX; Sabriá J; Rodríguez-Alvarez J Neurobiol Dis; 2009 Sep; 35(3):438-47. PubMed ID: 19555759 [TBL] [Abstract][Full Text] [Related]
19. Staurosporine-induced apoptosis in P388D1 macrophages involves both extrinsic and intrinsic pathways. Nakamura-López Y; Sarmiento-Silva RE; Moran-Andrade J; Gómez-García B Cell Biol Int; 2009 Sep; 33(9):1026-31. PubMed ID: 19524691 [TBL] [Abstract][Full Text] [Related]
20. [CMTM5 inhibits the tumor cell behavior of prostate cancer by downregulation of HER2]. Xu T; Li J; Xiao YB; Liu ZH; Li Q; Wang XF Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):386-90. PubMed ID: 20721248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]